Literature DB >> 27476124

Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia.

Herbert Lepor1.   

Abstract

Over the last 2 decades the evolution of alpha-blockers for lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) has been to preserve effectiveness, improve tolerability, and eliminate dose titration. Today, alpha-blockers represent the first-line treatment of most men with BPH whereby the primary objective is relief from bothersome LUTS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-blockers; BPH; Lower urinary tract symptoms; Medical management BPH

Mesh:

Substances:

Year:  2016        PMID: 27476124     DOI: 10.1016/j.ucl.2016.04.009

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  12 in total

Review 1.  Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?

Authors:  Lisa L Abler; Chad M Vezina
Journal:  Respir Physiol Neurobiol       Date:  2017-09-18       Impact factor: 1.931

Review 2.  Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia.

Authors:  Youngjoo Kwon
Journal:  Food Sci Biotechnol       Date:  2019-04-17       Impact factor: 2.391

Review 3.  Is Tamsulosin Linked to Dementia in the Elderly?

Authors:  Jason K Frankel; Yinghui Duan; Peter C Albertsen
Journal:  Curr Urol Rep       Date:  2018-07-03       Impact factor: 3.092

Review 4.  Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate.

Authors:  Stefan Ückert; George T Kedia; Dimitrios Tsikas; Annika Simon; Andreas Bannowsky; Markus A Kuczyk
Journal:  World J Urol       Date:  2019-09-10       Impact factor: 4.226

5.  Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats.

Authors:  Hyun Hwangbo; Da He Kwon; Eun Ok Choi; Min Yeong Kim; Kyu Im Ahn; Seon Yeong Ji; Jong Sik Kim; Kyung-Il Kim; No-Jin Park; Bum Hoi Kim; Gi-Young Kim; Su-Hyun Hong; Cheol Park; Ji-Suk Jeong; Yung Hyun Choi
Journal:  Nutr Res Pract       Date:  2018-07-23       Impact factor: 1.926

6.  In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia.

Authors:  Young-Jin Choi; Meiqi Fan; Yujiao Tang; Hyun Pil Yang; Ji-Young Hwang; Eun-Kyung Kim
Journal:  Nutrients       Date:  2019-10-14       Impact factor: 5.717

7.  Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.

Authors:  Jiakuan Liu; Tian Fang; Meiqian Li; Yuting Song; Junzun Li; Zesheng Xue; Jiaxuan Li; Dandan Bu; Wei Liu; Qinghe Zeng; Yidan Zhang; Shifeng Yun; Ruimin Huang; Jun Yan
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

8.  Experimental research in rats on the reactivity of new corneal blood vessels to adrenaline.

Authors:  Bianca Damian Daniela; Mihai Ghiță Aurelian; Istrate Sânziana; Cristina Coman Ioana
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

9.  Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

Authors:  Eu Chang Hwang; Shreyas Gandhi; Jae Hung Jung; Mari Imamura; Myung Ha Kim; Ran Pang; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2018-10-11

Review 10.  Pharmacology of the lower urinary tract: update on LUTS treatment.

Authors:  Pedro Abreu-Mendes; João Silva; Francisco Cruz
Journal:  Ther Adv Urol       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.